PyInvesting

Market research

002788.SHE Luyan Pharma Co.,Ltd

SHE CNY Healthcare

Latest close

9.39 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
4B
P/E ratio
14.39
Analyst target
Not available
Dividend yield
3.5%
Beta
-0.01

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

Luyan Pharma Co.,Ltd is currently in a long term downtrend where the price is trading 8.0% below its 200 day moving average.

From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.

Luyan Pharma Co.,Ltd's total revenue rose by 5.9% to $4B since the same quarter in the previous year.

Its net income has increased by 10.1% to $83M since the same quarter in the previous year.

Finally, its free cash flow fell by 134.1% to $-264M since the same quarter in the previous year.

Based on the above factors, Luyan Pharma Co.,Ltd gets an overall score of 3/5.